Rate-Setting Bills | Association for Accessible Medicines
New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework

Rate-Setting Bills

AAM’s core mission is to improve patients’ lives by advancing timely access to affordable, FDA-approved generic and biosimilar medicines. AAM is the nation’s leading trade association for manufacturers and distributors of generic and biosimilar prescription medicines. Our members provide more than 36,000 jobs at nearly 150 facilities, and manufacture more than 61 billion doses of prescription medicine in the US annually.

Key Points:

  • Rate-setting laws may work for public utilities, but not for prescription medicines.
  • States have no more authority to enact “rate setting” laws than “price fixing” laws.
  • Rate-setting laws could limit treatment options.
  • Price controls will exacerbate drug shortages.

Download Fact Sheet


Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.